BRACKMANN CHRISTOPH (Chief Financial Officer) sold 3.4% of their position (6.41K shares) of NOVOCURE LTD on the open market
Open‑market sale worth $85.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/5/2026ACC: 0002048634-26-000001
Officer· Chief Financial Officer
Since Mar 2026
+129.40K
Net shares
Net buyer
$85.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
135.81K acquired · 6.41K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+55.14K
Price / share
—
Trade value
—
% of position
41.1%
3/3/2026
134.12K→189.25K
Ordinary Shares
Direct
Shares
−6.41K
Price / share
$13.31
Trade value
$85.31K
% of position
3.4%
3/4/2026
189.25K→182.84K
Total
Net shares
+48.73K
Net value
-$85.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/3/2026 | A · Award | +55.14K | — | — | 41.1% | 134.12K | 189.25K |
| Ordinary Shares Direct | 3/4/2026 | S · Sale | −6.41K | $13.31 | $85.31K | 3.4% | 189.25K | 182.84K |
| Total | +48.73K | -$85.31K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Ordinary Shares
80.67K shares
Shares
+80.67K
Strike price
13.30
Held after
80.67K
Exercisable
—
3/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Ordinary Shares80.67K shares | 3/3/2026 | A · Award | +80.67K | 13.30 | — | 80.67K |